London-based Doctify, a healthcare review platform, has raised an additional $7.5M (approx €6.3M) in a fresh round of funding. The additional investment was led by Keen Venture Partners, with participation from existing investors including Amadeus Capital, Guinness Asset Management, as well as Tom Teichman (an early-stage investor in Doctify).
With the latest funding round, the company has raised an overall investment of $20M (approx €16.8), to date.
Promoting trust & transparency in healthcare
Founded in 2016 by NHS surgeons, Dr Stephanie Eltz and Dr Suman Saha, Doctify is an online platform that allows patients to review, choose, and book appointments with doctors.
The platform allows healthcare providers to collect and digitise patient feedback and publish it through multiple channels (both externally and internally). According to the company, the SaaS tool provides insights and analytics into the care they provide. It means patients can read real-time verified feedback for a hospital, clinic, or doctor for a specific condition or procedure.
The platform allows patients to choose from more than 3,000 specialist doctors in London and Southeast England from 47 different medical specialities. All the specialists on Doctify are verified by the company. Further, doctors can be compared based on patient reviews and filtered based on criteria like distance, availability, and insurer.
The company aims to increase trust and transparency in healthcare by providing access to verified patient reviews. With review platforms such as Glassdoor and Trustpilot helping people build trust in businesses, Doctify claims to be pioneering in the healthcare review space.
Currently, the company has operations in the UK, Austria, UAE, and Germany with plans to expand into major healthcare markets.
Doctify has connected over 4 million people with over 25,000 healthcare providers in the last 5 years. Some of its clients include prime hospital groups such as HCA, Royal Brompton Hospital, and Priory Group.
Funds to further expand in Europe
Doctify’s CEO Stephanie Eltz says, “We are thrilled to partner with investors to fuel our continued growth and accomplish Doctify’s mission of helping 30 million people across the globe to find the right specialist by 2023. We believe that by empowering providers to better capture patient feedback with technology, we can drive tangible improvements in healthcare.”
The raised capital will enable Doctify to fuel further growth in Germany, Europe’s largest healthcare market. With the passing of the Digital Healthcare Act (DVG), Germany is on a cusp of a digital transformation to become the leading provider of patient-centred digital healthcare.
In addition, the platform is also planning to further develop its Doctify Insights & Analytics Tool for healthcare providers to gain better insights into their patient feedback. With access to real-time reviews, benchmarking data, and real patient feedback, the tool will help providers to further understand, learn, and improve from the experiences of patients.
About Keen Venture Partners
Based out of Amsterdam and London, Keen Venture Partners is a venture capital firm that invests in territories such as Europe. It generally invests in tech startups operating in sectors such as data and intelligence; software services, and digital models.
The firm with a €120M fund, backs exceptional teams and fast-growing scaleups across Europe at the Series A and Series B stages. The investment in Doctify benefits from the support of the European Union under the Equity Facility for Growth established by the Council establishing a Programme for the Competitiveness of Enterprises and small and medium enterprises (COSME).
